Transforming the pharmacuitical industry to find novel ways of utilizing technology and research to develop high-quality and affordable medicines.
Bio Santafe is having world class manufacturing facilities are spread accross Mexico,USA,Canada,Australia,India and Japan.
These facilities benchmarked to international standards are set up to meet stringent quality standards,playing a critical role in achieving our global growth aspirations
Our All Facilities are approved by International regulatory agencies like US FDA, UK MHRA, Japan's MHLW,TGA Australia, and the MCC South Afirica
Bio Santafe Lifecare Pvt Ltd has a sound strategy to navigate a world with a growing, aging population and continuously evolving healthcare needs. Our strategy supports the Bio Santafe Lifecare Pvt Ltd purpose and is centered around four key areas: holding ourselves to the highest ethical standards, being part of the solution on pricing and access to medicines, helping tackle global health challenges and being a responsible citizen
Innovative medicines are not enough to impact diseases. To be effective at treating, curing or preventing diseases, medicine must be made available to the people and communities that need our treatments.
Our Access to Medicines programs help people overcome barriers to treatment in more than 140 low- and middle-income countries. These programs expand disease awareness, address stigma and support front-line services and care.
The healthcare landscape in the United States can be complex and difficult to navigate. Our Patient Support programs help ease the burden this can place on patients and families. These programs provide access to medicines, copay assistance and counseling across our therapeutic areas. Because we’re committed to building a better, healthier world for everyone to live in.
Research and Development (R&D) forms an integral part of our business strategy. With research and development sites across the globe, our recent R&D endeavour have led to significant progress in many areas including New Chemical Entity (NCE) program. Additionally, our foray into the Advanced Drug Delivery Systems (ADDS) has resulted in platform technologies that are used to develop value-added generic pharmaceuticals.
Bio Santafe Lifecare Pvt Ltd recognizes that the development of innovative medicines for life-threatening diseases is only one aspect of improving public health. We also invest in programs that promote prevention, strengthen healthcare infrastructure, and provide education and social and financial support to the most vulnerable communities around the world.
By enabling access to medicines, challenging assumptions, fighting stigma and collaborating with partners worldwide, we work not simply to treat some of the world’s most challenging public health threats – but to eliminate them.
Bio Santafe Lifecare Pvt Ltd operates in many communities around the world. We believe our impact should be positive, enriching and sustainable. Our goal is to promote efforts that minimize our effect on climate change and lower our consumption of natural resources. We seek to increase renewable energy use and recycling efforts, lessen our contribution to greenhouse gas (GHG) emissions and improve chemistry practices. Sustainability is core to how we work to Create Possible with people, partners and communities around the world.
To make good on our commitment to sustainability,Bio Santafe Lifecare Pvt Ltd has joined the world’s leading companies to reduce GHG emissions. Climate change presents a material threat to human health and environments worldwide.Bio Santafe Lifecare Pvt Ltd is committed to mitigating our impact by doing our part to improve our environmental practices though conservation and pollution prevention. This includes reaching our target goal to reduce our global Scope 1 and 2 GHG emissions by 25% by 2025, compared to our 2016 emissions.
As part of our ongoing efforts to address a wide range of global challenges that affect communities worldwide, we have chosen to join other like-minded companies in support of the United Nations Global Compact (UNGC) — a voluntary initiative that’s designed to align industries in the name of human rights, labor standards, environmental protection and anti-corruption practices. This is why we’ve begun to integrate the UNGC principles into our strategy, culture and day-to-day operations, to help create a better future for all people.
We joined other industry-leading companies across the globe in support of the United Nations Sustainable Development Goals (UN SDGs) so we can work together to discover ways to make positive contributions to society. As we expand our business and operations, we strive to further support global health and sustainable development. And by aligning our existing sustainability and social practices within the UNGC and the UN SDGs, we better articulate our commitment to our patients, local communities, society and the planet.
The Bio Santafe Lifecare Pvt Ltd Code of Ethics requires employees' compliance with all laws and mandates fair dealing in all instances. Violations of our Code of Ethics by employees are not tolerated and can lead to disciplinary action, including termination of employment and referral for criminal prosecution. As part of our commitment to ensure our products are free from violations of all types of ethical standards, we plan to update our Code of Ethics and employee training materials to include provisions specifically targeted to address human slavery and trafficking.
We routinely evaluate and address the risk of ethical violations for all countries involved in our supply chain. We do not routinely engage a third party to conduct this evaluation. Rather, we rely on official government information to identify risks and act accordingly. Our product ingredients are sourced primarily from countries the United States Department of State has designated as being compliant with the Trafficking Victims Protection Act's (TVPA) minimum standards. We take extra precautions before sourcing product from countries that are still making efforts to bring themselves into full compliance with the TVPA. For example, in those countries, we source only from businesses that are affiliated with countries fully compliant with TVPA, visit our suppliers along with their intermediates and vendors in person and only select suppliers that have been in business long enough to verify that their conduct meets Bio Santafe Lifecare Pvt Ltd ethical standards.
Since Bio Santafe Lifecare Pvt Ltd’s inception, employees have worked together to contribute to our mission of advancing patient care by developing groundbreaking therapeutics to treat life-threatening diseases. Fundamental to this mission is Bio Santafe Lifecare Pvt Ltd’s adherence to the highest legal and ethical standards of business conduct. As a company driven by science and dedicated to improving patient care and quality of life, Bio Santafe Lifecare Pvt Ltd is committed to such standards, as adherence to these protects patient safety, the company, its employees and business customers.
It is the responsibility of every Bio Santafe Lifecare Pvt Ltd employee to be knowledgeable about, and comply with, Bio Santafe Lifecare Pvt Ltd’s business conduct policies. The company believes working together to move its business forward in the spirit of these policies will continue to enhance the reputation of Bio Santafe Lifecare Pvt Ltd Sciences.
Proliferation of counterfeit and diverted medicines has developed into a global problem and poses a serious threat to patient safety.
According to the World Health Organization ("WHO"), "A counterfeit medicine is one which is deliberately and fraudulently mislabeled with respect to identity and/or source. Counterfeiting can apply to both branded and generic products, and counterfeit products may include products with correct ingredients or wrong ingredients, with insufficient quantity of active ingredient or with fake packaging."i Counterfeit products also include medicines that were genuinely manufactured, but where packaging or documents relating to the medicine's history/distribution were altered.ii Such products may include genuine medicines approved for sale in one market, but illegally diverted and sold elsewhere.
Counterfeit medicines can pose serious and sometimes life-threatening health risks to patients. The WHO notes that counterfeit medicines are not equivalent in quality, safety, and efficacy to genuine medicines and often do not contain any, or the correct amount of, active ingredient, and also may contain impurities.iii Additionally, counterfeit medicines may be produced in unsafe manufacturing conditionsiv and travel through insecure supply chains. Nor are counterfeits inspected by government regulators charged with the wellbeing of patients and product safety.v
At Bio Santafe Lifecare Pvt Ltd we are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world. The nature of Bio Santafe Lifecare Pvt Ltd's products makes ensuring authenticity and safety of our medicines fundamentally important.
Bio Santafe Lifecare Pvt Ltd's Anti-Counterfeiting Team consists of brand protection, legal, security, supply chain, quality, and packaging professionals who collaborate to address the threat to patient safety associated with counterfeiting and diversion of Bio Santafe Lifecare Pvt Ltd medicines. Bio Santafe Lifecare Pvt Ltd's Anti-Counterfeiting Team uses measures to detect, stop, deter, and report illicit sales of counterfeit medicines.


?6
7
8
9
10
'
M
v
The
New
York
copyright
reserved
Botanical
Garden
Ç
Chionanthus
compactus
Sw.
det.
RICHARD
A.
HOWARD
THE
GRENADINES
St.
Vincent
territory,
British
West
Indies
Linociera
caribaea
(Jacq.)
Knobl.
Bush
of
^1
to
tree
of
20¥;
fruit
green.
Dry
woodlands
on
Bequia
R.
A.
Howard
1121(2.
March
26-81,
Apr.
8-20,
1950
01497537
Legend -
Level of confidence that token is an accurately-transcribed word
extremely low
very low
low
undetermined
medium
high
very high